Pharming announces positive Phase II topline data for leniolisib in PIDs with immune dysregulation accepted as late-breaking abstract at ESID 2026

  • Leniolisib was generally well-tolerated, with clinical improvements across multiple measures of immune dysregulation, including reductions in lymphoproliferation
  • Separately, Pharming expects to report topline results from a Phase II trial of leniolisib in CVID in Q4 2026

Leiden, the Netherlands, September 22, 2026: Pharming (Euronext Amsterdam: PHARM/Nasdaq: PHAR), a global biotechnology company focused on rare immune and genetic diseases, today announced that a late-breaking abstract highlighting positive topline data from its Phase II trial with leniolisib in genetically identifiable primary immunodeficiencies (PIDs) with immune dysregulation linked to PI3Kd signaling has been accepted at the 22nd Biennial Meeting of the European Society for Immunodeficiencies (ESID), which will take place October 14-17, in the Netherlands.

This trial is a single-arm, open-label, intra-patient dose-escalation Phase II study of leniolisib evaluating safety and tolerability, pharmacokinetic, pharmacodynamic and efficacy measures in 13 subjects with genetically defined PIDs. The abstract will highlight leniolisib’s favorable safety and tolerability profile, as well as clinical improvements across measures of immune dysregulation. Clinical results included improvements in lymphoproliferative disease, with a mean 26.4% spleen volume reduction (SVR) and reductions in the size of index lesions. The safety observations were consistent with the known safety profile of leniolisib, with infections as the most common events observed in study subjects, and no new safety signals identified. Additional data will be presented at ESID 2026.  

Of the 13 patients enrolled in the study, nine also had a diagnosis of common variable immunodeficiency (CVID). Pharming expects to report Phase II results for leniolisib in CVID patients with immune dysregulation, with or without an identified genetic cause, in the fourth quarter of 2026.

“These results mark an important step in assessing leniolisib’s potential to address immune dysregulation in PIDs beyond APDS, potentially benefiting a substantially larger patient population,” said Anurag Relan, Chief Medical Officer of Pharming. “Given PI3Kδ’s central role in immune dysregulation mechanisms, these results are encouraging and support ongoing development of leniolisib in PID patients with APDS-like manifestations. We look forward to sharing additional results from this trial at ESID, along with topline results from our separate Phase II trial in CVID, expected in the fourth quarter, which will inform our plans for a potential registrational study in the broader CVID population.”

Abstract
details:

Title: Single-arm, open-label, Phase 2 study of leniolisib in patients with inborn errors of immunity linked to dysregulated PI3K pathway signaling: Topline safety and efficacy outcomes 
Author: Gulbu Uzel, MD

The presentation will be available for viewing at ESID 2026 for the full duration of conference.

About leniolisib

Leniolisib is an oral small molecule phosphoinositide 3-kinase delta (PI3Kẟ) inhibitor approved as the first and only targeted treatment of activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) in adult and pediatric patients 12 years of age and older in the U.S., U.K., Australia, Israel, the EU, Canada, and South Korea; in children 4 to 11 years of age who weigh at least 27 kg in the U.S., and for patients 4 years of age and older in Japan.

Leniolisib inhibits the production of phosphatidylinositol-3-4-5-trisphosphate, which serves as an important cellular messenger and regulates a multitude of cell functions such as proliferation, differentiation, cytokine production, cell survival, angiogenesis, and metabolism. Results from a randomized, placebo-controlled Phase III clinical trial demonstrated statistically significant improvement in the coprimary endpoints, reflecting a favorable impact on the immune dysregulation and deficiency seen in these patients, and open label extension data has supported the safety and tolerability of long-term leniolisib administration.1,2

Leniolisib is currently under regulatory review for the treatment of APDS in several other countries. Leniolisib is also being evaluated in two Phase II clinical trials in primary immunodeficiencies (PIDs) with immune dysregulation. The safety and efficacy of leniolisib has not been established for PIDs with immune dysregulation beyond APDS.

About Pharming

Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is a global biotechnology company that develops and commercializes innovative medicines for people living with rare immune and genetic diseases.

We combine specialized scientific, medical, regulatory and commercial expertise to advance a focused portfolio of approved medicines and development programs that address significant unmet medical needs. Guided by insights from patients and the wider rare disease community, we are dedicated to delivering innovative therapies for some of the most challenging rare diseases.

Pharming is headquartered in Leiden, the Netherlands, with operations in the United States and Europe.

For more information, visit www.pharming.com and find us on LinkedIn.
  
Forward-looking Statements
This press release may contain forward-looking statements. Forward-looking statements are statements of future expectations that are based on management’s current expectations and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance, or events to differ materially from those expressed or implied in these statements. These forward-looking statements are identified by their use of terms and phrases such as “aim”, “ambition”, ‘‘anticipate’’, ‘‘believe’’, ‘‘could’’, ‘‘estimate’’, ‘‘expect’’, ‘‘goals’’, ‘‘intend’’, ‘‘may’’, “milestones”, ‘‘objectives’’, ‘‘outlook’’, ‘‘plan’’, ‘‘probably’’, ‘‘project’’, ‘‘risks’’, “schedule”, ‘‘seek’’, ‘‘should’’, ‘‘target’’, ‘‘will’’ and similar terms and phrases. Examples of forward-looking statements may include statements with respect to timing and progress of Pharming’s preclinical studies and clinical trials of its product candidates, Pharming’s clinical and commercial prospects, and Pharming’s expectations regarding its projected working capital requirements and cash resources, which statements are subject to a number of risks, uncertainties and assumptions, including, but not limited to the scope, progress and expansion of Pharming’s clinical trials and ramifications for the cost thereof; and clinical, scientific, regulatory, commercial, competitive and technical developments. In light of these risks and uncertainties, and other risks and uncertainties that are described in Pharming’s 2025 Annual Report and the Annual Report on Form 20-F for the year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission, the events and circumstances discussed in such forward-looking statements may not occur, and Pharming’s actual results could differ materially and adversely from those anticipated or implied thereby. All forward-looking statements contained in this press release are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. Readers should not place undue reliance on forward-looking statements. Any forward-looking statements speak only as of the date of this press release and are based on information available to Pharming as of the date of this release. Pharming does not undertake any obligation to publicly update or revise any forward-looking statement as a result of new information, future events or other information.

References 

  1. Rao VK, et al. Blood. 2023;141(9):971-983.
  2. Rao VK, et al. J Allergy Clin Immunol 2024;153:265-74.

For further public information, contact:

Pharming

Michael Levitan, VP Investor Relations & Capital Markets 
T: +1 (908) 705 1696 
E: [email protected] 

Saskia Mehring, Head of Corporate Communications 
T: +31 6 28 32 60 41 
E: [email protected] 

Media Relations 
Julia Deutsch (Lyra Strategic Advisory on behalf of Pharming)
E: [email protected]

Netherlands: Leon Melens (LifeSpring Life Sciences Communication on behalf of Pharming) 
T: +31 6 53 81 64 27 

Attachment



Omdia: Mainland China PC market grows 11% in Q2, shipments forecast to fall 6% in 2026

Omdia: Mainland China PC market grows 11% in Q2, shipments forecast to fall 6% in 2026

LONDON–(BUSINESS WIRE)–
MainlandChina’s PC shipments grew 11% year-over-year (YoY) in 2Q26 to 11.4 million units, according to the latest Omdia data. Desktop shipments surged 42%, offsetting a 2% decline in notebook shipments, with the two categories accounting for 4.3 million and 7.1 million units, respectively. Meanwhile, tablet shipments in mainland China declined 13% to 8.0 million units, amid weaker demand and ongoing supply challenges.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260921910544/en/

Mainland China desktop, notebook and tablet shipments, estimates and forecasts, 1Q24-4Q27

Mainland China desktop, notebook and tablet shipments, estimates and forecasts, 1Q24-4Q27

Omdia’s latest forecast projects mainland China’s PC shipments will decline 6% in 2026 to 39.7 million units. Tablet shipments are also expected to fall 10% to 32.5 million units for the full year.

The mainland China PC market outperformed expectations in 2Q, primarily supported by strong commercial demand, with shipments in the segment rising 29%. Growth was driven in large part by a surge in refresh activity linked to China’s XinChuang (Information Technology Application Innovation) initiative, which supports the adoption of domestic IT technologies. In contrast, the consumer segment remained relatively weak, with shipments declining 2%.

“Commercial PC demand in mainland China, particularly from large enterprises and government organizations, continues to support growth in the broader market,” said Emma Xu, Senior Analyst at Omdia. “Consumer demand has weakened this year following the fading impact of government subsidies and rising prices. However, inventory stockpiling to lock in lower prices and mitigate the risk of further cost increases helped prevent a sharper decline in the consumer segment in 2Q.

“The tablet market faces greater challenges after several years of growth. Consumer demand is weakening, while vendors have less scope to support sales through promotional activity. The market is entering a more mature and stable phase, with penetration at historically high levels and demand increasingly shifting toward replacement cycles rather than first-time ownership,” added Xu.

For full-year 2026, Omdia expects mainland China’s PC market to decline 6% YoY, with consumer shipments falling 10%. Growth in the commercial segment is expected to partially offset weakness in the broader market. Meanwhile, the tablet market is forecast to contract 10% in 2026, reflecting weak demand and continued supply constraints.

People’s Republic of China (mainland) desktop and notebook shipments and annual growth

Omdia PC Market Pulse: Q2 2026

Vendor

(company)

Q2 2026 shipments

Q2 2026 Market share

Q2 2025 shipments

Q2 2025 Market share

Annual growth

Lenovo

3.7

32%

3.4

34%

7%

Huawei

1.8

16%

1.0

10%

82%

iSoftStone

1.4

12%

0.8

8%

71%

Apple

1.2

10%

0.7

7%

63%

Asus

0.8

7%

0.9

9%

-5%

Others

2.5

22%

3.4

33%

-26%

Total

11.4

100%

10.2

100%

11%

 

 

Note: Unit shipments in millions. Percentages may not add up to 100% due to rounding.

Source: Omdia PC Horizon Service (sell-in shipments), August 2026

 

People’s Republic of China (mainland) tablets shipments and annual growth

Omdia PC Market Pulse: Q2 2026

Vendor

(company)

Q2 2026 shipments

Q2 2026 Market share

Q2 2025 shipments

Q2 2025 Market share

Annual growth

Huawei

2.1

26%

2.5

28%

-18%

Apple

2.0

25%

2.2

24%

-10%

Lenovo

1.2

15%

0.8

8%

63%

Xiaomi

0.7

9%

1.2

13%

-37%

HONOR

0.6

7%

0.8

9%

-29%

Others

1.4

18%

1.8

19%

-19%

Total

8.0

100%

9.3

100%

-13%

 

 

Note: Unit shipments in millions. Percentages may not add up to 100% due to rounding.

Source: Omdia PC Horizon Service (sell-in shipments), August 2026

 

People’s Republic of China (mainland) PC forecast

Omdia PC Forecast: 2024 to 2026

Segment

2024

2025

2026

2025 Annual growth

2026 Annual growth

Consumer

23.6

24.1

21.6

2%

-10%

Commercial

13.3

14.4

13.8

8%

-4%

Government and education

2.8

3.7

4.3

32%

16%

Total

39.6

42.1

39.7

6%

-6%

Note: Unit shipments in millions. Percentages may not add up to 100% due to rounding.

 

Source: Omdia PC Horizon Service, Forecast, August 2026

People’s Republic of China (mainland) tablets forecast

Omdia PC Forecast: 2024 to 2026

Segment

2024

2025

2026

2025 Annual growth

2026 Annual growth

Consumer

26.4

30.2

26.2

14%

-13%

Commercial

3.7

4.1

4.6

10%

12%

Government and education

1.5

1.7

1.7

16%

3%

Total

31.5

36.0

32.5

14%

-10%

 

Note: Unit shipments in millions. Percentages may not add up to 100% due to rounding.

Source: Omdia PC Horizon Service, Forecast, August 2026

ABOUT OMDIA

Omdia, part of TechTarget, Inc. d/b/a Informa TechTarget (Nasdaq: TTGT), is a technology research and advisory group. Our deep knowledge of tech markets, grounded in real conversations with industry leaders and hundreds of thousands of data points, make our market intelligence our clients’ strategic advantage. From R&D to ROI, we identify the greatest opportunities and move the industry forward.

Fasiha Khan: [email protected]

Eric Thoo: [email protected]

KEYWORDS: China United States United Kingdom North America Asia Pacific Europe

INDUSTRY KEYWORDS: Software Other Retail Internet Hardware Consumer Electronics Technology Retail Other Technology

MEDIA:

Photo
Photo
Mainland China desktop, notebook and tablet shipments, estimates and forecasts, 1Q24-4Q27
Logo
Logo

On Enters Next Chapter: Unveils Strategy to Redefine What a Sportswear Brand Can Be Alongside 2029 Financial Targets

On Enters Next Chapter: Unveils Strategy to Redefine What a Sportswear Brand Can Be Alongside 2029 Financial Targets

  • At its Investor Day, On today introduces its strategy to redefine what a sportswear brand can be, aimed at the Movement Class, a generation for whom sportswear is an identity.

  • Built on its Premium Playbook, On plans for strong growth across all verticals through 2029. Its immediate key growth pillars, Run, Sneaker, and Apparel, are expected to drive outsized contribution, further supported by the entry into new sports categories, Football and Golf.

  • As a result, On introduces the ambition to achieve a high-teens constant currency net sales CAGR through 2029, sustain an industry-leading gross profit margin of at least 65%, and drive meaningful SG&A leverage. This results in an adjusted EBITDA margin ambition of at least 22% by 2029 and a three-year adjusted EBITDA CAGR of more than 20%.

  • Reflecting the strong cash generation of its Premium Playbook, On today lays out a disciplined capital allocation policy. On’s Board of Directors has authorized an inaugural share repurchase of up to an aggregate of USD 1 billion of Class A Ordinary Shares through the end of 2029.

  • On is also on track to significantly exceed the 2026 financial targets it introduced at its Investor Day 2023, and reiterates its outlook for the full-year 2026.

ZURICH–(BUSINESS WIRE)–
On Holding AG (NYSE: ONON) (“On” or the “Company”), the Swiss premium sportswear brand, hosts its 2026 Investor Day today at On Labs in Zurich. As its current three-year horizon draws to a close, the Leadership Team presents the Company’s strategy and mid-term financial targets for the 2026–2029 period, detailing its vision to redefine what a sportswear brand can be. This includes further details on the entry into new sports categories Football and Golf, as On continues to establish itself as the most premium global sportswear brand.

The On Premium Playbook

The On Premium Playbook is the mechanism behind the Company’s 2029 ambitions. At the Investor Day, the Company’s leadership presents the framework and its five reinforcing steps:

  • Create innovative products. An obsession with breakthrough innovation to create products designed for performance and expression. It begins at On Labs in Zurich, where exceptional talent and an entrepreneurial culture intersect. By combining material science, structural superfoams, and radical manufacturing platforms, On creates distinctive, premium performance products designed to set new standards.
  • Validate through athletes and talents. Product credibility is earned at the highest levels of performance. On’s innovations are validated through authentic partnerships with elite global athletes on championship and Olympic stages, driving genuine brand preference and cultural relevance. The Company prioritizes earned brand equity over promotional spending to build long-term consumer desire.
  • Deliver premium experiences. Elevated engagement across global markets, to deepen consumer relationships. On connects with consumers through immersive brand experiences across its owned Direct-to-Consumer (DTC) channel and strategic wholesale partners, deepening customer engagement across global markets.
  • Capture high quality earnings. Differentiated offerings and experiences provide the baseline for strong demand generation and capture across new and existing fans. On’s discipline in execution and reinvestment will enable a high full-price share and strong financial outcome in the form of premium growth.
  • Invest in a culture of innovation and excellence. Strong financial results directly fund the future, allowing for sustained investment in people and technology to foster a culture of bold ideas and high performance. Operating cash flow is reinvested into On’s world-class team, collaborative culture, and advanced R&D capabilities, allowing for sustained innovation leadership.

Financial Ambitions Through 2029

To anchor its next era of profitable expansion through fiscal year 2029, On is setting new financial targets guided by the On Premium Playbook, built on three drivers of premium growth: multi-dimensional top-line growth across verticals, regions, and channels; an industry-leading gross profit margin; and operating cost leverage and productivity gains from a business at greater scale. For the 2026–2029 period, On is introducing the following new mid-term financial ambitions:

  • Net sales: High-teens constant currency growth and corresponding absolute net sales reaching at least CHF 5.6 billion in 2029 (approaching USD 7 billion) at current FX rates.
  • Gross profit margin: Commitment to an industry-leading gross profit margin of 65.0%+ throughout the period.
  • Adjusted EBITDA margin: Ambition to reach an Adjusted EBITDA margin of 22%+ by 2029.
  • The above dynamics result in a target adjusted EBITDA CAGR above 20% for the 2026–2029 period.

Share Repurchase Authorization

Reflecting On’s strong balance sheet and the highly cash generative nature of its premium growth, the Company intends to return capital to shareholders as part of a disciplined capital allocation strategy. On has received authorization from its Board of Directors in September, 2026 to repurchase up to an aggregate of USD 1 billion of its Class A Ordinary shares through the end of December 2029.

Lead Independent Director Appointment

On also announces the appointment of Laura Miele as Lead Independent Director, effective September 21, 2026. Laura has served on On’s Board of Directors and its Audit Committee since 2024, and was appointed to the newly created role by On’s independent directors.

Laura is President of Enterprise Development at Electronic Arts, responsible for strategic growth areas beyond EA’s core business that build on the company’s strengths and extend across entertainment. She joined EA in 1996 and has since held commercial, creative and technology leadership roles across the company, including President of EA Entertainment, Chief Operating Officer and Chief Studios Officer.

2026 Outlook

The Company reiterates its full-year 2026 outlook: constant currency net sales growth in the low-20% range, a gross profit margin of at least 65.0%, and an adjusted EBITDA margin in the range of 19.5% to 20.0%.

These figures exclude the benefit of tariff refunds. Up to USD 65 million (up to CHF 53m at current FX rates) are expected to be received in the third quarter of 2026, with this amount anticipated to benefit the quarter’s reported gross profit.

For the third quarter of 2026, On further expects to achieve a constant currency net sales growth rate of around 17%. This reflects the disciplined wholesale sell-in execution On introduced in context of its second quarter results as well as the continued strong momentum in its DTC channel.

Executive Commentary

David Allemann, Founder and Co-CEO of On, said: “Almost seventeen years ago, On started from a radical idea. We asked whether running could feel fundamentally different, and whether elite performance could merge with elevated contemporary design. Today, we are setting out to redefine what a sportswear brand can be, building at a scale we could not have imagined back then. With the On Premium Playbook, we are setting out to connect the innovation from our On Labs in Zurich to a growing population of global fans for whom movement is no longer utility, but identity, and who carry that into how they dress, where they shop and who they follow.”

Caspar Coppetti, Founder and Co-CEO of On, said: “We are on track to significantly overachieve our targets given at the last Investor Day in 2023. For the period through 2029, we are committing to premium as our northstar, staying focused on the long term, and executing on each turn of the On Premium Playbook. It is simple in principle, demanding in practice, and powerful because it compounds: Top-line expansion and margin expansion are not in conflict at On; they are complementary outputs of our Premium Playbook.”

Frank Sluis, CFO of On, said: “Our outlook firmly establishes On as a high-quality earnings compounder. The demand is premium and multi-dimensional, with strength across all verticals and every region and every channel contributing. This enables us to maintain an industry-leading gross profit margin of at least 65.0%, while continuing to invest in our business. At this scale, it also converts into meaningful SG&A leverage, driving strong, compounding adjusted EBITDA growth.”

Webcast Information

A live webcast of the presentations and Q&A session will be available on September 22, 2026 at 8:00 a.m. U.S. Eastern Time (2:00 p.m. Central European Time) on the Company’s investor relations website at investors.on.com and via the following link. A recording will be available after the live event.

The full year 2026 guidance, financial targets and other material information to be discussed at the Investor Day are contained in this press release or have been previously disclosed by On.

For a detailed description and a reconciliation of the non-IFRS measures presented in this release to the nearest IFRS measure, see the section titled “Non-IFRS Measures”.

About On

On was born in the Swiss Alps in 2010 with the mission to ignite the human spirit through movement – a mission that still guides the brand today. Sixteen years after market launch, On delivers industry-disrupting innovation in premium footwear, apparel and accessories for high-performance running, outdoor, training, all-day activities and tennis. On’s award-winning CloudTec® and LightSpray™ innovation, purposeful design and groundbreaking strides within the circular economy have attracted a fast-growing global fan base – inspiring humans to explore, discover and Dream On.

On is present in more than 90 countries globally and engages with a digital community on www.on.com.

Forward-Looking Statements

This press release contains statements that may constitute “forward-looking” statements pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Many of the forward-looking statements contained in this press release can be identified by the use of forward-looking words such as “anticipate,” “believe,” “continue,” “could,” “expect,” “estimate,” “forecast,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “target,” “will,” “would,” and “should,” among others, although the absence of these words does not mean that a statement is not forward-looking.

Among other things, On’s quotations from management in this press release and other written materials, as well as On’s strategic and operational plans, contain forward-looking statements. Forward-looking statements in this press release and in the materials to be presented at our Investor Day today include, but are not limited to, statements regarding our full year 2026 guidance for net sales, gross profit margin and adjusted EBITDA margin; our medium- and long-term financial targets and outlook; our growth strategy across geographies, channels and product categories; planned retail store openings and our DTC expansion; our product pipeline and innovation roadmap, including LightSpray™; our entry into and development of new sports categories, including football and golf; our sustainability strategy, goals and targets; anticipated change and impact of our reporting currency; supply chain, sourcing and manufacturing capacity plans; and our capital allocation and investment priorities.

On may also make written or oral forward-looking statements in its periodic reports to the SEC, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties, including in the presentation and remarks at our Investor Day today. Further, On uses the investors.on-running.com website as well as LinkedIn as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Forward-looking statements are based on our management’s beliefs and assumptions and on information currently available to our management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to, those identified under the section titled “Risk Factors” in our Annual Report on Form 20-F for the year ended December 31, 2025 and in our subsequent reports on Form 6-K.

These risks and uncertainties include factors relating to: the strength of our brand and our ability to maintain our reputation and premium brand image; our ability and the ability of our independent manufacturers and other suppliers to follow responsible business practices; our ability to implement our growth strategy; the concentration of our business in a single, discretionary product category, namely footwear, apparel and accessories; our ability to successfully enter and compete in new sports categories, including football and golf, and to develop products for those categories; our dependence on relationships with elite athletes, ambassadors and other high-profile talent, and the potential impact on our brand of conduct by, or the loss of, any such individual; our ability to continue to innovate and meet consumer expectations; changes in consumer tastes and preferences including in products and sustainability, and our ability to connect with our consumer base; our ability to open new stores at locations that will attract customers to our premium products; our ability to compete and conduct our business in the future; health epidemics, pandemics and similar outbreaks; general economic, political, demographic and business conditions worldwide, including geopolitical uncertainty and instability, such as the on-going Russia-Ukraine or Israel-Hamas conflicts and on-going shipping disruptions in the Red Sea and surrounding waterways; the success of operating initiatives, including advertising and promotional efforts and new product and concept development by us and our competitors; our ability to successfully develop, implement, and scale our LightSpray™ technology and products developed using this technology; our ability to strengthen and grow our DTC channel; our ability to address climate related risks; our ability to execute and manage our sustainability strategy and achieve our sustainability-related goals and targets, including sustainable product offerings and investor and customer scrutiny; our third-party suppliers, manufacturers and other partners, including their financial stability and our ability to find suitable partners to implement our growth strategy; supply chain disruptions, inflation and increased costs in supplies, goods and transportation, customs and duty expenses, and foreign exchange rates; the availability of qualified personnel and the ability to retain such personnel, including our Executive Officers; our ability to accurately forecast demand for our products and manage product manufacturing decisions; our ability to distribute products through our wholesale channel; changes in commodity, material, labor, distribution and other operating costs; our international operations; our ability to protect our intellectual property and defend against allegations of violations of third-party intellectual property by us; cybersecurity incidents and other disruptions to our information technology (“IT”) systems; increased hacking activity against the critical infrastructure of any nation or organization that retaliates against Russia for its invasion of Ukraine; our reliance on complex IT systems; our ability to adopt and monitor generative artificial intelligence (“AI”) technologies in our operations; changes and contemplation of changes to trade policies, tariffs and import/export regulations in the United States and other jurisdictions; our ability to achieve our full year 2026 guidance, and the assumptions underlying that guidance, including with respect to consumer demand, foreign exchange rates, tariffs and input costs; our ability to achieve the medium- and long-term financial targets and other objectives described in this press release and to be presented at our Investor Day within the timeframes indicated or at all; financial accounting and tax matters; our ability to maintain effective internal control over financial reporting; the potential impact of, and our compliance with, new and existing laws and regulations; other factors that may affect our financial condition, liquidity and results of operations; and other risks and uncertainties set out in filings made from time to time with the SEC and available at www.sec.gov, including, without limitation, our most recent reports on Form 20-F and Form 6-K.

You are urged to consider these factors carefully in evaluating the forward-looking statements contained herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements.

Forward-looking statements speak only as of the date they are made, and we do not undertake any obligation to update them in light of new information or future developments or to release publicly any revisions to these statements in order to reflect later events or circumstances or to reflect the occurrence of unanticipated events.

Non-IFRS Financial Measures

Adjusted EBITDA, adjusted EBITDA margin, adjusted EBITDA CAGR, Free Cash Flow, SG&A excluding share-based compensation, net sales on a constant currency, and constant currency net sales CAGR are financial measures that are not defined under IFRS. We use these non-IFRS measures when evaluating our performance, including when making financial and operating decisions, and as a key component in the determination of variable incentive compensation for employees. We believe that, in addition to conventional measures prepared in accordance with IFRS, these non-IFRS measures enhance investor understanding of our financial and operating performance from period to period, because they enhance the comparability of results between periods, help identify trends in operating results and provide additional insight and transparency on how management evaluates the business. Adjusted EBITDA, adjusted EBITDA margin and adjusted EBITDA CAGR, and SG&A excluding SBC exclude share-based compensation, which is not viewed by management as part of our ongoing operations and performance. In particular, we believe adjusted EBITDA and adjusted EBITDA margin are measures commonly used by investors to evaluate companies in the sportswear industry. Net sales on a constant currency basis and constant currency net sales CAGR are non-IFRS financial measures and should be viewed as a supplement to our results under IFRS. Net sales on a constant currency basis and constant currency net sales CAGR represent current period results that have been retranslated using exchange rates used in the prior year comparative period. We provide these metrics within our results, to enhance the visibility of the underlying growth rate of net sales, excluding the impact of foreign currency exchange rate fluctuations. However, these measures should not be considered in isolation or as a substitute for other financial measures calculated and presented in accordance with IFRS and may not be comparable to similarly titled non-IFRS measures used by other companies.

Other than with respect to IFRS net sales and gross profit margin, On only provides guidance on a non-IFRS basis. We do not provide a reconciliation of forward-looking adjusted EBITDA, adjusted EBITDA margin, adjusted EBITDA CAGR net sales growth on a constant currency basis and constant currency net sales CAGR to IFRS net income, IFRS net income margin, or IFRS net income CAGR, net sales growth and net sales CAGR, respectively, because we are unable to quantify, without unreasonable efforts, certain amounts that are necessary for such a reconciliation. The reconciling items we are unable to quantify include share-based compensation expense, income tax expense, net finance expense, depreciation and amortization and foreign currency exchange rate fluctuations. The amount of these deductions may be material and, therefore, could result in projected net income, net income margin, net income CAGR, net sales growth and net sales CAGR being materially different than projected adjusted EBITDA, adjusted EBITDA margin, adjusted EBITDA CAGR, net sales growth on a constant currency basis and constant currency net sales CAGR. These statements represent forward-looking information, and actual results may vary materially. Please see the risks and assumptions referred to in the Forward-Looking Statements section of this press release.

Reconciliations of historical non-IFRS measures to their most directly comparable IFRS measures are available in our most recent reports on Form 20-F and Form 6-K, filed with the SEC and available at www.sec.gov, and on our investor relations website at investors.on-running.com.

Source: On

Category: Corporate

Investor:

On Holding AG

Liv Radlinger

[email protected]

or

ICR, Inc.

Brendon Frey

[email protected]

Media:

On Holding AG

Adib Sisani

[email protected]

KEYWORDS: Switzerland Europe

INDUSTRY KEYWORDS: Sports General Sports

MEDIA:

Logo
Logo

Fluence Energy (NASDAQ: FLNC) Faces Investor Scrutiny Amid Additional Surprises About Houston Facility — HBSS

SAN FRANCISCO, Sept. 21, 2026 (GLOBE NEWSWIRE) — On September 17, 2026, investors in Fluence Energy, Inc. (NASDAQ: FLNC) saw the price of their shares slide $1.39 (-15%) after the company held a business update call revealing more significant problems with its supply chain facility in Houston, Texas and that it fired its Chief Product Officer on September 11, 2026.

The developments have prompted national shareholders rights firm Hagens Berman to open an investigation into whether Fluence has been sufficiently transparent about the operational readiness of the facility, including negative financial effects, and, if not, whether the company may have violated federal securities laws.

The firm urges Fluence investors who suffered substantial losses to submit your losses now. In addition, persons with knowledge who may be able to assist the investigation are invited to contact the firm’s attorneys.

Visit:
www.hbsslaw.com/FLNC

Direct Contact Email:
[email protected]

Firm Telephone: 844-916-0895

Fluence Energy, Inc. (FLNC) Investigation:

On August 21, 2025, Fluence announced that its expansion of U.S. domestic supply chain in partnership with Bergstrom Inc. was underway at a new manufacturing facility in Houston, Texas. The facility produces thermal management systems for its Gridstack ProTM battery energy storage solutions.

The company emphasized in the announcement that “[t]he Houston facility plays a crucial role in the company’s strategy to onshore production of every major product and component of a grid-scale battery energy storage system to the United States.”

In response, the market sent the price of Fluence shares up 10% the next day.

By August 5, 2026, investors learned more about the Houston facility, when Fluence reported weaker than expected Q3 2026 revenues, a GAAP gross profit margin of just 5.1% compared to 14.8% in the same quarter last year, and a net loss of $44.3 million compared to net income of $6.2 million in the same quarter last year.

During the earnings call the next day, management assured investors that the Houston facility was “fully automated” but that completion of it had been delayed by a few months in part because of “delays in construction.” CEO Julian Jose Nebreda Marquez provided further assurances, stating “as I said, we’re ramping up Houston and that we believe we have it under control.”

This news, along with the dramatic guidance reduction due to “under control” delays, drove the price of Fluence shares down over 7% on August 6.

Then, on September 16, 2026, investors learned more troubling news centered on the facility. Among other things, management:

  • Slashed its 2026 revenue guidance another $600 million (-20%);
  • Said “[m]ore than 80% of the expected revenue decrease is attributable to US production issues[;]”
  • Revealed ongoing problems with the Houston customized automated welding process;
  • Said “the speed of final assembly of components into finished product […] lags our expectations[;]” and
  • Explained (in apparent contrast to the “fully automated” narrative) that “they switched to manual welding[.]”

The market swiftly reacted, sending the price of Fluence shares down over 15% the next day, and several analysts reportedly cut their ratings and price targets for the stock.

“We’re focused on when the Houston welding issue was first known to Fluence management given the facility’s crucial role in onshoring,” said Reed Kathrein, the Hagens Berman partner leading the firm’s investigation.

If you invested in Fluence and have substantial losses, or have knowledge that will assist the firm’s investigation, submit your losses now »

Whistleblowers: Persons with non-public information regarding Fluence should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman

Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw

Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.

Contact: Hagens Berman, Reed Kathrein, 715 Hearst Avenue, Suite 300, Berkeley, CA 94710, 844-916-0895, [email protected]



Shareholders who lost money in shares of acquired Lincoln Educational Services Corporation (NASDAQ: LINC) should contact Wolf Haldenstein Immediately

Lead Plaintiff Deadline November 10, 2026

NEW YORK, Sept. 21, 2026 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein”), a nationally recognized securities litigation law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased Lincoln Educational Services Corporation (“Lincoln” or the “Company”) (NASDAQ: LINC) common stock between May 11, 2026 and August 9, 2026, inclusive (the “Class Period”).

Investors who purchased Lincoln shares during the class period and suffered losses may be eligible to participate in the case, with the lead-plaintiff deadline set for November 10, 2026.


PLEASE CLICK HERE TO SUBMIT CONTACT AND TRADE INFORMATION

The filed complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failing to disclose material adverse facts to investors, including that:

  • that the Company’s admissions process was not effectively converting students from enrollment to start;
  • that, as a result, the Company was experiencing a significant drop in student starts relative to enrollment; and
  • that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

On August 10, 2026, before the market opened, Lincoln reported earnings for the second quarter of 2026. Among other things, the Company reported student starts increased by only 1% year over year despite enrollment growing 9%, “as fewer enrolled students than expected attended the first day of class.”

The Company further disclosed that “during the quarter, we observed changes in the student decision-making process that affected conversion from enrollment to start” and that Lincoln “has taken, and will continue to take, actions to address these trends . . . .”

On this news, Lincoln’s stock price fell $10.22 or 24.93% to close at $30.77 on August 10, 2026.


WHY WOLF HALDENSTEIN?

This illustrious firm, founded in 1888, is steadfast in their pursuit of justice for investors who have suffered financial harm due to these misrepresented statements. The law firm brings to the fore over 125 years of legal expertise in securities litigation and has a proven record of protecting the rights of investors.

We encourage all investors who have been affected or have information that will assist in our investigation, to contact Wolf Haldenstein Adler Freeman & Herz LLP.

There is no cost or obligation to speak with an attorney.

Contact:

Firm Website:
 Wolf Haldenstein Adler Freeman & Herz LLP

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.



TC Energy announces sale of Guadalajara-Manzanillo Pipeline

Generates cash proceeds of approximately $560 million (US$400 million)

High-grading portfolio to redeploy proceeds towards accretive growth opportunities across TC Energy’s North American footprint

CALGARY, Alberta, Sept. 21, 2026 (GLOBE NEWSWIRE) — TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or the Company) today announced it has entered into an agreement to sell Energía Occidente de México (EOM), the entity that owns the Guadalajara-Manzanillo Pipeline, to affiliates of ESENTIA Energy Development, S.A.B. de C.V. (ESENTIA) for a gross purchase price of $560 million (US$400 million). The 313-kilometre Guadalajara-Manzanillo Pipeline transports up to 500 MMcf/d of natural gas, connecting imported LNG supply near Manzanillo and continental gas supply near Guadalajara to power plants and industrial customers in the states of Colima and Jalisco.

This transaction is anticipated to close in the first half of 2027, and is subject to customary closing conditions, regulatory approvals and consents.

“This transaction reflects our continued focus on portfolio optimization and long-term value creation,” said François Poirier, President and Chief Executive Officer of TC Energy. “The transaction will support our disciplined capital allocation strategy, creating optionality to redeploy proceeds from a mature asset towards high-value growth opportunities across our North American footprint. With more than 30 years of history in Mexico, and as the largest Canadian investor in the country, TC Energy remains committed to reliably delivering the natural gas that supports the country’s expanding energy needs, strengthens energy security and enables future economic development.”

TC Energy and ESENTIA will work together to support a safe and orderly transition of operations of this critical natural gas system.

Following closing, TC Energy will continue to own and operate its broader Mexico natural gas pipeline network, including approximately 3,300 kilometres of pipeline and 8.7 Bcf/d of installed natural gas transportation capacity.

About TC Energy

We are a leader in North American energy infrastructure, spanning Canada, the U.S. and Mexico. For over 75 years, we have proudly connected the world to the energy it needs. Every day, we move more than 30 per cent of the natural gas used across the continent and connect LNG exports to global markets—powering communities and industries. Complemented by strategic ownership and low-risk investments in power generation, our infrastructure delivers affordable, reliable and sustainable energy across North America. 

We carry forward a legacy of nation-building energy infrastructure and strong partnerships. By working with communities, businesses and leaders across our extensive energy network, we create opportunities today and for generations to come. 

TC Energy’s common shares trade on the Toronto (TSX) and New York (NYSE) stock exchanges under the symbol TRP. To learn more, visit us at TCEnergy.com.

FORWARD-LOOKING INFORMATION

This release contains certain information that is forward-looking and is subject to important risks and uncertainties (such statements are usually accompanied by words such as “anticipate”, “expect”, “believe”, “may”, “will”, “should”, “estimate”, “intend” or other similar words). Forward-looking statements in this document may include, but are not limited to, statements related to the anticipated closing of the transaction in the first half of 2027; expected cash proceeds of approximately $560 million (US$400 million); the expected use of proceeds; and TC Energy’s strategic priorities, disciplined capital allocation and financial flexibility.

Our forward-looking information is based on certain key assumptions and is subject to risks and uncertainties, including but not limited to: the timely receipt of all necessary regulatory and third-party approvals; the satisfaction of customary closing conditions or other conditions to the sale; fluctuations in interest, tax and foreign exchange rates and changes in regulatory, political or business environments.

Forward-looking statements and future-oriented financial information in this document are intended to provide TC Energy security holders and potential investors with information regarding TC Energy and its subsidiaries, including management’s assessment of TC Energy’s and its subsidiaries’ future plans and financial outlook. All forward-looking statements reflect TC Energy’s beliefs and assumptions based on information available at the time the statements were made and as such are not guarantees of future performance. As actual results could vary significantly from the forward-looking information, you should not put undue reliance on forward-looking information and should not use future-oriented information or financial outlooks for anything other than their intended purpose. We do not update our forward-looking information due to new information or future events, unless we are required to by law. For additional information on the assumptions made, and the risks and uncertainties which could cause actual results to differ from the anticipated results, refer to the most recent Quarterly Report to Shareholders and the 2025 Annual Report filed under TC Energy’s profile on SEDAR+ at www.sedarplus.ca and with the U.S. Securities and Exchange Commission at www.sec.gov and the “Forward-looking information” section of our Report on Sustainability which is available on our website at www.TCEnergy.com.

-30-

Media Inquiries:

Media Relations
[email protected]
403-920-7859 or 800-608-7859

Investor & Analyst Inquiries:

Investor Relations
[email protected]
403-920-7911 or 800-361-6522

PDF available: http://ml.globenewswire.com/Resource/Download/790c1139-7905-44af-87f3-a5bc9e92d884



Elastic Introduces jina-ocr-v1: End-to-End Document Processing in a Single Frontier-Grade Model

Elastic Introduces jina-ocr-v1: End-to-End Document Processing in a Single Frontier-Grade Model

New OCR model processes complex layouts, tables, handwriting, and math across 100+ languages with frontier-grade accuracy at a fraction of the size and cost

SAN FRANCISCO–(BUSINESS WIRE)–Elastic (NYSE: ESTC) today announced the launch of jina-ocr-v1, a new optical character recognition (OCR) model for end-to-end document processing. At 574M active parameters, it delivers frontier-grade accuracy in a model roughly one tenth the size of the benchmark leader. Jina-ocr-v1 accurately converts complex visual documents into structured, machine-readable text, such as Markdown, in a single pass, making it easy to search, train models, and build agentic applications using the data from scanned documents.

While traditional OCR works well on clean text and simple layouts, complex documents with highly visual content often require separate processing steps, such as page segmentation, element classification, text recognition and reassembly. Each step introduces potential for errors that can accumulate through the fragile processing pipeline. When inaccurate or incomplete data is passed downstream, agents can return incomplete facts, and RAG pipelines can return answers that don’t accurately reflect the source documents.

jina-ocr-v1 handles the entire process end to end in a single model. It uses a mixture-of-experts architecture with 3.4B total parameters and 574M active at inference, running at the speed and cost of a sub-600M model. jina-ocr-v1 also adds FastMTP technology, which improves multi-token prediction to accelerate inference.

In a single model, jina-ocr-v1 can:

  • Work across a broad range of imaged documents: Processes images of varying quality, including scanned pages, photographed documents, slides and label images from source formats such as PDF, PPTX and XLSX.
  • Preserve document structure: Processes complex layouts and returns structured Markdown that retains headings, sections, lists and reading order.
  • Extract tables: Converts tables into basic HTML format, suitable for further processing and importing into spreadsheets or other applications.
  • Recognize handwriting: Reads handwriting, including block text in a wide array of languages, and English cursive.
  • Read more than 100 languages: Understands a wide array of global languages and scripts, with all major international languages and scripts represented.
  • Convert mathematical notation: Transforms printed formulas into LaTeX math code for use in documents and scientific applications.

At a tenth the size of the olmOCR-bench leader, jina-ocr-v1 scores 83.4 on olmOCR-bench, the highest published score among models with fewer than 600M active parameters. It delivers frontier-grade accuracy on less hardware, outperforming frontier LLMs on character-level accuracy and reading order.

“Customers need an easy way to digitize their information more than ever in the age of AI,” said Han Xiao, vice president of AI, Elastic. “Traditional OCR pipelines break down with complex layouts, tables, handwriting and other highly visual content. Until now, companies either had to accept those limitations or pay a significant premium to use general-purpose LLMs for ingesting documents. We built jina-ocr-v1 to handle that full range of complexity in a single model, while remaining very efficient at scale.”

Availability

jina-ocr-v1 is available now via the Elastic Inference Service, included with Elastic Cloud, with preconfigured model provisioning and GPU acceleration. Developers can access the model through a preconfigured endpoint without hosting the model or provisioning their own GPUs.

  • Get started with the Jina API: Access jina-ocr-v1 on a pay-per-token basis through the Jina API.

  • Deploy jina-ocr-v1 on-premises: Run jina-ocr-v1 locally or on-premises using pre-built containers with commercial licensing from Elastic, or access the model through Hugging Face under CC BY-NC 4.0 for academic and noncommercial use.

Additional Materials

About Elastic

Elastic (NYSE: ESTC) integrates its deep expertise in search technology with artificial intelligence to help everyone transform all of their data into answers, actions, and outcomes. Elasticsearch, which is the foundation for its search, observability, and security solutions, is used by thousands of companies, including more than 75% of the Fortune 100. Learn more at elastic.co.

Elastic and associated marks are trademarks or registered trademarks of elasticsearch B.V. and its subsidiaries. All other company and product names may be trademarks of their respective owners.

Media Contact

Elastic PR

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Software Data Analytics Internet Artificial Intelligence Data Management Professional Services Technology Security

MEDIA:

Logo
Logo

IonQ and SDT Announce the First Strategic Partnership to Bring Both Advanced Quantum Computing and Quantum Networking to the Asia-Pacific Region

IonQ and SDT Announce the First Strategic Partnership to Bring Both Advanced Quantum Computing and Quantum Networking to the Asia-Pacific Region

Deployment will bring the first IonQ Superion 256 system and first silicon-vacancy quantum memory module to South Korea

SEOUL, Republic of Korea & COLLEGE PARK, Md.–(BUSINESS WIRE)–IonQ (NYSE: IONQ), the world’s leading full-stack quantum platform and foundry, today announced a strategic partnership with Korea-based quantum technology and software company SDT, Inc. Under this multi-year collaboration IonQ will supply SDT with a Superion 256 quantum computer as well as IonQ’s silicon-vacancy (SiV) quantum memory module.

“Demand for our new Superion 256 system is growing globally, and this agreement in Asia Pacific is yet another example of our clients combining IonQ’s leading quantum computers with our quantum networking and quantum memory solutions,” said Niccolo de Masi, Chairman and CEO of IonQ. “IonQ is very proud to be expanding our commercial footprint in South Korea as well as continuing to trailblaze quantum cancer and biomedical research. This purchase equips SDT with the building blocks for both high-performance quantum computing and quantum data centers of the future.”

The partnership expands the two companies’ ongoing collaboration from cloud-based software integration to physical hardware production, assembly, and regional resale partnership. The Superion 256 system is planned for deployment with an SDT customer in South Korea, where IonQ and SDT intend to collaborate on a hybrid quantum-classical data center. SDT also plans to establish a dedicated quantum manufacturing and system-integration facility in Gumi, South Korea. That will be the site for IonQ’s SiV quantum memory packaging and manufacturing, quantum system assembly, integration and commissioning.

“IonQ leads the global quantum industry in both technology and manufacturing innovation,” said Jiwon Yune, CEO of SDT. “Our objective is to make our new Gumi facility a key operational hub for IonQ’s global supply chain and regional deployment by hosting manufacturing operations and assembling world-class quantum systems. Alongside this manufacturing partnership, SDT will participate in the assembly and operation of IonQ quantum systems and actively pursue opportunities to manufacture more quantum components. Our role will also extend to a separate in-country cancer center project where we intend to develop hybrid quantum-classical infrastructure for medical and biomedical research with IonQ. Together, these initiatives put SDT’s quantum design and manufacturing strategy into practice through assembly, operations and system integration, while opening opportunities in manufacturing and regional commercialization.”

This announcement reinforces IonQ’s regional commitment as evidenced through its collaborations with other partnerships in Korea including: KISTI, SK Telecom, Hyundai Motor Company, and leading academic institutions such as Seoul National University and Sungkyunkwan University.

About IonQ

IonQ, Inc. [NYSE: IONQ] is the world’s leading quantum platform and foundry – delivering integrated quantum solutions across computing, networking, sensing, and security. IonQ’s newest generation of quantum computers, the Superion, is the latest in a line of cutting-edge systems. Earlier systems have helped customers and partners including Amazon Web Services, AstraZeneca, and NVIDIA achieve a 20x performance increase over previous quantum solutions and accelerate innovation in drug discovery, materials science, financial modeling, logistics, cybersecurity, and defense. In 2025, the company achieved 99.99% two-qubit gate fidelity, setting a world record in quantum computing performance.

Headquartered in College Park, Maryland, IonQ has operations across North America, Latin America, EMEA, and APAC. Our quantum computing services have been available through all major cloud providers since 2021, while we also meet the needs of networking and sensing customers across land, sea, air, and space. IonQ is making quantum platforms more accessible and impactful than ever before. Learn more at IonQ.com.

About SDT Inc.

SDT Inc. is a South Korea-based quantum technology company providing full-stack hardware, software, and system integration across the quantum value chain. Named a World Economic Forum Technology Pioneer in 2026, SDT supports quantum system assembly, integration, and hybrid quantum-classical data center development in the Asia-Pacific region.

Note to Investors Regarding Forward Looking Statements

This press release contains forward-looking statements. All statements contained in this press release other than statements of historical fact are forward-looking statements, including statements regarding our partnership with SDT, Inc. In some cases, you can identify these statements by forward-looking words such as “pending,” “look forward,” “accelerate,” “anticipate,” “expect,” “suggest,” “plan,” “believe,” “intend,” “estimate,” “target,” “project,” “should,” “could,” “would,” “may,” “will,” “forecast,” “confident,” “position,” “become,” “on track,” “ensure,” “ongoing” and other similar expressions. These statements are only predictions based on our expectations and projections about future events as of the date of this press release and are subject to a number of risks, uncertainties and assumptions that may prove incorrect, any of which could cause actual results to differ materially from those expressed or implied by such statements, including, among others, those described under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the Securities and Exchange Commission, or SEC, and in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 to be filed with the SEC. New risks emerge from time to time, and it is not possible for our management to predict all risks, nor can management assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statement we make. Investors are cautioned not to place undue reliance on any such forward-looking statements, which speak only as of the date they are made. Except as otherwise required by law, we undertake no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

IonQ Media Contacts:
Cheryl Krauss
[email protected]

Tor Constantino
[email protected]

IonQ Investor Contact:
[email protected]

KEYWORDS: South Korea United States North America Asia Pacific Maryland

INDUSTRY KEYWORDS: Defense Automotive Manufacturing General Automotive Technology Logistics/Supply Chain Management Manufacturing Semiconductor Other Energy Utilities Alternative Energy Energy Science Automotive Air Transport Software Research Networks Other Defense Internet Contracts Hardware

MEDIA:

Logo
Logo

ServisFirst Bancshares, Inc. Declares Third Quarter Cash Dividend

BIRMINGHAM, Ala., Sept. 21, 2026 (GLOBE NEWSWIRE) — ServisFirst Bancshares, Inc., (NYSE: SFBS) (“ServisFirst”), the holding company for ServisFirst Bank, today announces: At a meeting held on September 21, 2026, its Board of Directors declared a quarterly cash dividend of $0.19 per share, payable on October 9, 2026, to stockholders of record as of October 1, 2026.  

About ServisFirst Bancshares, Inc.

ServisFirst Bancshares, Inc. is a bank holding company based in Birmingham, Alabama. Through its subsidiary ServisFirst Bank, ServisFirst Bancshares, Inc. provides business and personal financial services from locations in Alabama, Florida, Georgia, North and South Carolina, Tennessee, Texas and Virginia. Through the Bank, we originate commercial, consumer and other loans and accept deposits, provide electronic banking services, such as online and mobile banking, including remote deposit capture, deliver treasury and cash management services and provide correspondent banking services to other financial institutions. ServisFirst Bancshares, Inc. files periodic reports with the U.S. Securities and Exchange Commission (SEC). Copies of its filings may be obtained through the SEC’s website at www.sec.gov or at www.servisfirstbank.com.

More information about ServisFirst Bancshares, Inc. may be obtained over the Internet at www.servisfirstbank.com or by calling (205) 949-0302.

Contact: ServisFirst Bank
Davis Mange (205) 949-3420
[email protected]



Pricing of CNH Industrial Capital Canada Ltd. Cdn$200 million notes due 2028 and Cdn$350 million notes due 2030

Basildon, UK — 21 September
2026 —
CNH Industrial N.V.
(NYSE: CNH) today announced that its indirect wholly owned subsidiary, CNH Industrial Capital Canada Ltd., has priced (i) Cdn$200 million in aggregate principal amount of 4.00% notes due September 25, 2028, with an issue price of 99.935% (the “2028 Notes”) and (ii) Cdn$350 million in aggregate principal amount of 4.40% notes due September 25, 2030, with an issue price of 99.989% (the “2030 Notes”, and together with the 2028 Notes, the “Notes”). The Notes are being offered on a private placement basis to certain accredited investors in each of the provinces of Canada, which offering is expected to close on September 25, 2026, subject to the satisfaction of customary closing conditions.

CNH Industrial Capital Canada Ltd. intends to add the net proceeds from the offering to its general funds and use them for working capital and other general corporate purposes, including, among other things, the purchase of receivables or other assets in the ordinary course of business, as well as the repayment of indebtedness as it becomes due.

The Notes, which are senior unsecured obligations of CNH Industrial Capital Canada Ltd., will in each case pay interest semi-annually on March 25 and September 25 of each year, beginning on March 25, 2027, and will in each case be guaranteed by CNH Industrial Capital LLC, CNH Industrial Capital America LLC and New Holland Credit Company, LLC, each an indirect wholly owned subsidiary of CNH Industrial N.V.

***

The securities offered in the private placement have not been and will not be qualified for sale to the public under applicable securities laws in Canada and, accordingly, any offer and sale of the securities in Canada will be made on a basis which is exempt from the prospectus requirements of such securities laws.

The securities offered in the private placement have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or applicable state securities laws. Accordingly, the securities may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any of these securities, nor shall there be any sale of these securities, in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful. This press release is being issued pursuant to and in accordance with Rule 135c under the Securities Act.


CNH Industrial Capital LLC

is an indirect wholly owned subsidiary of CNH Industrial N.V. and is headquartered in Waterford, Wisconsin. As a captive finance company, the primary business of CNH Industrial Capital LLC and its subsidiaries is to underwrite and manage financing products for end-use customers and dealers of CNH Industrial America LLC and CNH Industrial Canada Ltd. (collectively, “CNH Industrial North America”) and provide other related financial products and services to support the sale of agricultural and construction equipment sold by CNH Industrial North America. CNH Industrial Capital LLC and its subsidiaries also provide wholesale and retail financing related to new and used agricultural and construction equipment manufactured by entities other than CNH Industrial North America. CNH Industrial Capital LLC’s principal executive offices are located at 1 CNH Way, Waterford, WI 53185, and the telephone number is +1(262) 636-6011.

Attachment